Skip to content

Clinical trials

Completed Phase 1 Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 1 Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20102
20112
20121
20135
20142
20151
20172
20181
20191
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zynex Monitoring Solutions2
Beijing Tiantan Hospital1
Boehringer Ingelheim1
Cellphire Therapeutics, Inc.1
Daiichi Sankyo1
Entegrion, Inc.1
George Washington University1
Haemostatix Ltd1
HemCon Medical Technologies, Inc1
International Partnership for Microbicides, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage23
Hemostatic Disorders3
Cerebral Hemorrhage2
Abdominal Pain1
Anemia, Aplastic1
Carcinoma, Hepatocellular1
Cardiovascular Diseases1
Cerebrovascular Disorders1
Dental Plaque1
Dyspnea1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.